Home > Insider Trading > Filing (0000914190-12-000520)

Filing Details

Accession Number:: 0000914190-12-000520
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-08-23 17:51:20
Reporting Period:: 2012-08-21

Filing Date:: 2012-08-23
Accepted Time:: 2012-08-23 17:51:20
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1180145	Cardiovascular Systems Inc	CSII	Surgical & Medical Instruments & Apparatus (3841)	411698056

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1428216	J Robert Thatcher	651 Campus Drive St. Paul MN 55112	Executive Vp	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2012-08-21	1,828	$9.19	127,195	No	4	S	Direct
Common Stock	Disposition	2012-08-22	310	$9.02	126,885	No	4	S	Direct
Common Stock	Disposition	2012-08-23	1,151	$8.90	125,734	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (right to buy)	$12.37		2015-10-16	64,700	64,700	Direct
Common Stock	Stock Option (right to buy)	$8.83		2016-12-18	7,764	7,764	Direct
Common Stock	Stock Option (right to buy)	$8.83		2017-04-17	29,762	29,762	Direct
Common Stock	Stock Option (right to buy)	$7.90		2017-08-06	22,645	22,645	Direct
Common Stock	Stock Option (right to buy)	$12.15		2017-12-11	32,350	32,350	Direct
Common Stock	Stock Option (right to buy)	$8.75		2019-03-01	11,646	11,646	Direct
Common Stock	Warrant	$8.83	2009-02-25	2014-02-24	3,045	3,045	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2015-10-16	64,700	64,700	Direct
2016-12-18	7,764	7,764	Direct
2017-04-17	29,762	29,762	Direct
2017-08-06	22,645	22,645	Direct
2017-12-11	32,350	32,350	Direct
2019-03-01	11,646	11,646	Direct
2014-02-24	3,045	3,045	Direct

Footnotes

In connection with the vesting and delivery of restricted stock, and pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2011, on each date shares were sold and the net proceeds were used to pay required withholding taxes.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.00 to $9.39 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.00 to $9.08 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.74 to $8.99 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Fully exercisable.